Alpha-cinnamide compounds and compositions as hdac8 inhibitors
US-2016264518-A1 · Sep 15, 2016 · US
US11420910B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11420910-B2 |
| Application number | US-201515522859-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 29, 2015 |
| Priority date | Oct 30, 2014 |
| Publication date | Aug 23, 2022 |
| Grant date | Aug 23, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
New chelators such as H3L1, H3L2, H3L3, H3L26 and derivatives were synthesized for the complexation of {Al18F}2+. These new chelators are able to complex {AI18F}2+ with good radiochemical yields using a labeling temperature of 37° C. The stability of the new Al18F-complexes was tested in phosphate buffered saline (PBS) at pH 7 and in rat serum. AI18F-L3 and AI18F-L26 showed a stability comparable to that of the previously reported Al18F-NODA. Moreover, the biodistribution of Al18F-L3 and AI18F-L26 showed absence of in vivo demetallation since only very limited bone uptake was observed, whereas the major fraction of activity 60 min p.i. was observed in liver and intestine due to hepatobiliary clearance of the radiolabeled ligand. The chelators H3L3 and Al18F-L26 demonstrated to be a good lead candidates for the labeling of heat sensitive biomolecules with 18F-fluorine and derivatives have been synthesized. We have explored the complexation of {AI18F}2+ with new chelators and obtained very favourable radiochemical yields (>85%) using a labeling temperature of 37° C. The stability of the new Al18F-complexes was tested in phosphate buffered saline (PBS) at pH 7 and in rat serum at 37° C., where AI18F-L3 and AI18F-L26 showed a stability comparable to that of the previously reported Al18F-NODA. Moreover, the biodistribution of Al18F-L3 and Al18F-L26 showed high stability, since only very limited bone uptake—which would be an indication of release of fluorine-18 in the form of fluoride—was observed, whereas the major fraction of activity 60 min p.i. was observed in liver and intestines due to hepatobiliary clearance of the radiolabeled ligand. The chelators H3L3 and H3L26 demonstrated to be good lead candidates for the labeling of heat sensitive biomolecules with 18F-fluorine and several derivatives have been synthesized.
Opening claim text (preview).
The invention claimed is: 1. A chelate of {Al 18 F} 2+ with a compound selected from the group consisting of: a compound having the formula (I): wherein: n2 is 4, wherein the 6-membered ring is cyclic without additional substituents, or includes a double bond, or is aromatic; Z is OH; R 7 is a —CH 2 -Ph-R′ group with R′ in ortho, meta or para position, wherein R′ is selected from the group consisting of a hydrogen atom, —COOH, —NH 2 , —N═C═S, —SH, an activated ester and a group bearing a maleimide adapted to couple with compounds bearing a suitable chemical function, the asymmetric carbon atoms are in (R) or (S) configuration, or a pharmaceutically acceptable salt thereof. 2. A kit for radiolabeling of a molecule with 18 F, including a heat sensitive molecule, whereby the kit comprises an {Al 18 F} 2+ chelate according to claim 1 , wherein the heat sensitive molecule is a peptide or a protein. 3. The kit according to claim 2 , whereby the kit further comprises reagents or media. 4. The chelate of claim 1 , wherein the chelate is obtained at a temperature <40° C.
having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton · CPC title
having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings · CPC title
conjugates with carriers being antibodies · CPC title
The ring being saturated · CPC title
not condensed with other rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.